FIELD: pharmacology, fluorinated quinolone-based drug, in particular ofloxacine for injections.
SUBSTANCE: claimed composition contains therapeutically acceptable amount of ofloxacine and trilon-B, sodium chloride, water for injections as additives.
EFFECT: high therapeutic effectiveness; non-crystallized active agent for a long-time storage.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INJECTION MOXIFLOXACIN SOLUTION AND METHOD FOR ITS PREPARING | 2006 |
|
RU2314103C1 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR THE TREATMENT OF PURULENT WOUNDS ON THE BASIS OF FLUOROQUINOLONS (OPTIONS) | 2016 |
|
RU2682171C2 |
| COMPOSITION AND METHOD OF PRODUCING EYE DROPS | 2014 |
|
RU2595837C2 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF DIOXIDINE | 2016 |
|
RU2667974C2 |
| PHARMACEUTICAL COMPOSITION ELICITING WITH ANTIBACTERIAL EFFECT AND METHOD FOR IT PREPARING | 2002 |
|
RU2230557C1 |
| OPHTHALMIC OINTMENT FORMULATION AND METHOD FOR PREPARING SAME | 2012 |
|
RU2531937C2 |
| METHOD FOR PREPARING METRONIDASOL SOLUTION FOR INJECTIONS | 2003 |
|
RU2245135C1 |
| CYPROFLOXACINE SOLUTION FOR INFUSION | 2005 |
|
RU2284811C1 |
| PHARMACEUTICAL COMPOSITION FOR PARENTERAL APPLICATION OF 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE AND METHOD OF OBTAINING SAID COMPOSITION | 2010 |
|
RU2419432C1 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF BACTERIOLYTIC AND PROTEOLYTIC COMPLEX OF ENZYMES | 2016 |
|
RU2655808C2 |
